Proton pump inhibitor use is not associated with cardiac arrhythmia in critically ill patients

Hypomagnesemia can lead to cardiac arrythmias. Recently, observational data have linked chronic proton pump inhibitor (PPI) exposure to hypomagnesemia. Whether PPI exposure increases the risk for arrhythmias has not been well studied. Using a large, single-center inception cohort of critically ill p...

Full description

Bibliographic Details
Main Authors: Chen, Kenneth P., Malley, Brian E., Danziger, John, Lee, Joonwu, Mark, Roger G, Feng, Mengling, Celi, Leo Anthony G.
Other Authors: Massachusetts Institute of Technology. Institute for Medical Engineering & Science
Format: Article
Language:en_US
Published: John Wiley & Sons, Inc. 2017
Online Access:http://hdl.handle.net/1721.1/106815
https://orcid.org/0000-0001-8593-9321
https://orcid.org/0000-0002-6318-2978
_version_ 1811091594913251328
author Chen, Kenneth P.
Malley, Brian E.
Danziger, John
Lee, Joonwu
Mark, Roger G
Feng, Mengling
Celi, Leo Anthony G.
author2 Massachusetts Institute of Technology. Institute for Medical Engineering & Science
author_facet Massachusetts Institute of Technology. Institute for Medical Engineering & Science
Chen, Kenneth P.
Malley, Brian E.
Danziger, John
Lee, Joonwu
Mark, Roger G
Feng, Mengling
Celi, Leo Anthony G.
author_sort Chen, Kenneth P.
collection MIT
description Hypomagnesemia can lead to cardiac arrythmias. Recently, observational data have linked chronic proton pump inhibitor (PPI) exposure to hypomagnesemia. Whether PPI exposure increases the risk for arrhythmias has not been well studied. Using a large, single-center inception cohort of critically ill patients, we examined whether PPI exposure was associated with admission electrocardiogram readings of a cardiac arrhythmia in more than 8000 patients. There were 25.4% PPI users, whereas 6% were taking a histamine 2 antagonist. In all, 14.0% had a cardiac arrhythmia. PPI use was associated with an unadjusted risk of arrhythmia of 1.15 (95% CI,1.00–1.32; P =.04) and an adjusted risk of arrhythmia of 0.91 (95% CI, 0.77–1.06; P =.22). Among diuretic users (n = 2476), PPI use was similarly not associated with an increased risk of cardiac arrhythmia. In summary, in a large cohort of critically ill patients, PPI exposure is not associated with an increased risk of cardiac arrhythmia.
first_indexed 2024-09-23T15:04:52Z
format Article
id mit-1721.1/106815
institution Massachusetts Institute of Technology
language en_US
last_indexed 2024-09-23T15:04:52Z
publishDate 2017
publisher John Wiley & Sons, Inc.
record_format dspace
spelling mit-1721.1/1068152022-09-29T12:34:40Z Proton pump inhibitor use is not associated with cardiac arrhythmia in critically ill patients Chen, Kenneth P. Malley, Brian E. Danziger, John Lee, Joonwu Mark, Roger G Feng, Mengling Celi, Leo Anthony G. Massachusetts Institute of Technology. Institute for Medical Engineering & Science Harvard University--MIT Division of Health Sciences and Technology Mark, Roger G Lee, Joonwu Mark, Roger G Feng, Mengling Celi, Leo Anthony G. Hypomagnesemia can lead to cardiac arrythmias. Recently, observational data have linked chronic proton pump inhibitor (PPI) exposure to hypomagnesemia. Whether PPI exposure increases the risk for arrhythmias has not been well studied. Using a large, single-center inception cohort of critically ill patients, we examined whether PPI exposure was associated with admission electrocardiogram readings of a cardiac arrhythmia in more than 8000 patients. There were 25.4% PPI users, whereas 6% were taking a histamine 2 antagonist. In all, 14.0% had a cardiac arrhythmia. PPI use was associated with an unadjusted risk of arrhythmia of 1.15 (95% CI,1.00–1.32; P =.04) and an adjusted risk of arrhythmia of 0.91 (95% CI, 0.77–1.06; P =.22). Among diuretic users (n = 2476), PPI use was similarly not associated with an increased risk of cardiac arrhythmia. In summary, in a large cohort of critically ill patients, PPI exposure is not associated with an increased risk of cardiac arrhythmia. National Institutes of Health (U.S.) (NIH Grant R01 EB017205) 2017-01-31T19:12:03Z 2017-01-31T19:12:03Z 2015-03 2015-02 Article http://purl.org/eprint/type/JournalArticle 00912700 http://hdl.handle.net/1721.1/106815 Chen, K. P., Lee, J., Mark, R. G., Feng, M., Celi, L. A., Malley, B. E. and Danziger, J. (2015), "Proton pump inhibitor use is not associated with cardiac arrhythmia in critically ill patients." Journal of Clinical Pharmacology, 55: 774-779. https://orcid.org/0000-0001-8593-9321 https://orcid.org/0000-0002-6318-2978 en_US http://dx.doi.org/10.1002/jcph.479 Journal of Clinical Pharmacology Creative Commons Attribution-Noncommercial-Share Alike http://creativecommons.org/licenses/by-nc-sa/4.0/ application/pdf John Wiley & Sons, Inc. Prof. Mark via Courtney Crummett
spellingShingle Chen, Kenneth P.
Malley, Brian E.
Danziger, John
Lee, Joonwu
Mark, Roger G
Feng, Mengling
Celi, Leo Anthony G.
Proton pump inhibitor use is not associated with cardiac arrhythmia in critically ill patients
title Proton pump inhibitor use is not associated with cardiac arrhythmia in critically ill patients
title_full Proton pump inhibitor use is not associated with cardiac arrhythmia in critically ill patients
title_fullStr Proton pump inhibitor use is not associated with cardiac arrhythmia in critically ill patients
title_full_unstemmed Proton pump inhibitor use is not associated with cardiac arrhythmia in critically ill patients
title_short Proton pump inhibitor use is not associated with cardiac arrhythmia in critically ill patients
title_sort proton pump inhibitor use is not associated with cardiac arrhythmia in critically ill patients
url http://hdl.handle.net/1721.1/106815
https://orcid.org/0000-0001-8593-9321
https://orcid.org/0000-0002-6318-2978
work_keys_str_mv AT chenkennethp protonpumpinhibitoruseisnotassociatedwithcardiacarrhythmiaincriticallyillpatients
AT malleybriane protonpumpinhibitoruseisnotassociatedwithcardiacarrhythmiaincriticallyillpatients
AT danzigerjohn protonpumpinhibitoruseisnotassociatedwithcardiacarrhythmiaincriticallyillpatients
AT leejoonwu protonpumpinhibitoruseisnotassociatedwithcardiacarrhythmiaincriticallyillpatients
AT markrogerg protonpumpinhibitoruseisnotassociatedwithcardiacarrhythmiaincriticallyillpatients
AT fengmengling protonpumpinhibitoruseisnotassociatedwithcardiacarrhythmiaincriticallyillpatients
AT celileoanthonyg protonpumpinhibitoruseisnotassociatedwithcardiacarrhythmiaincriticallyillpatients